Budget Difficulties Aside, Centers Important To NCI, Broder Asserts; Warns Against Sabotage.
In Brief: Simone Is AACI President-Elect; McGill, ICRC New Members; Engstrom ECOG Prevention Head
NCI Viewed As NIH’s ‘Administrative Reserve,” Broder Tells Directors
$1.5 Million In Direct Costs Is Proposed Core Grant Requirement
NCI Should Enhance Funding Of Centers Program, Porter Says
ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs
Healy Sworn In, Calls For ‘Operation Bethesda Storm’
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
